Molecular regulation of mast cell activation

Slides:



Advertisements
Similar presentations
Fc Receptors Oct. 28, 2009 Extra reading on web Daniel Conrad 423 MSB, I. CD23.
Advertisements

in out Lipid bilayer of plasma membrane Antigen recognition Signal transduction (contains one or more ITAMs) + - Src-family tyrosine kinase reversibly.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma  André Veillette, Huaijian Guo  Critical Reviews.
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
B-cell biology and development
Overview Events controlled by signaling
Mario J. Grijalva, Ph.D. (pronounced gree-HALL-va)
John W. Bloom, MD  Journal of Allergy and Clinical Immunology 
Anti-IgE as a mast cell–stabilizing therapeutic agent
Proximal signaling events in FcɛRI-mediated mast cell activation
Robert H. Oakley, PhD, John A. Cidlowski, PhD 
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
Laurent L'homme, PhD, David Dombrowicz, PhD 
Advances in food allergy in 2015
Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies  Nima Rezaei, MD, PhD, Mona Hedayat, MD,
Miriam Marqués, Francisco X. Real  European Urology 
Ali A Khorasani Bethany Bennett Jenna Rozacky November 21, 2011
Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA  Riccardo Sibilano, PhD, Barbara Frossi, PhD, Ryo Suzuki, PhD, Federica.
Biology of common β receptor–signaling cytokines
Katherine R. Groschwitz, BS, Simon P. Hogan, PhD 
Signaling molecules as therapeutic targets in allergic diseases
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Mechanisms of mast cell signaling in anaphylaxis
Is 9 more than 2 also in allergic airway inflammation?
ERK1/2 antagonize AMPK-dependent regulation of FcεRI-mediated mast cell activation and anaphylaxis  Seung-Lark Hwang, PhD, Yue Lu, PhD, Xian Li, MSc,
T-cell activation through the antigen receptor
Molecular regulation of mast cell activation
Severe asthma: Advances in current management and future therapy
TNF-α–induced protein 3 (A20): The immunological rheostat
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk  Jun Ho Lee, PhD, Jie Wan Kim,
Hepatitis B “X” gene linked to cellular calcium release
Zuhair K. Ballas, MD  Journal of Allergy and Clinical Immunology 
PKB Binding Proteins Cell
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein–coupled receptors  Charles D. Ulrich, Martin Holtmann‡,
T-cell activation through the antigen receptor
Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria  Tse Wen Chang, PhD, Christina Chen, BS, Chien-Jen.
The pathophysiology of anaphylaxis
B-cell biology and development
Charles E. Reed, MD, Hirohito Kita, MD 
AKT/PKB Signaling: Navigating Downstream
Molecular mechanisms of IgE regulation
Volume 123, Issue 6, Pages (December 2002)
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
Volume 22, Issue 1, Pages 9-18 (January 2005)
“Accentuate the negative, eliminate the positive”: Engineering allergy therapeutics to block allergic reactivity through negative signaling  Andrew Saxon,
Karin R. Engelhardt, Dr rer nat, Bodo Grimbacher, MD 
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Update on glucocorticoid action and resistance
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Molecular targets on mast cells and basophils for novel therapies
DJ-1 regulates mast cell activation and IgE-mediated allergic responses  Do Kyun Kim, PhD, Hyuk Soon Kim, MS, A-Ram Kim, MS, Ji Hyung Kim, BS, Bokyung.
Primary immunodeficiencies: A rapidly evolving story
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Targeting TNF-α: A novel therapeutic approach for asthma
TH9 immunodeficiency in patients with hyper-IgE syndrome
Vanessa L. Ott, PhD, John C. Cambier, PhD 
Innate immune responses to infection
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,
Genetic regulation of IgE responses: Achilles and the tortoise
Volume 7, Issue 1, Pages 1-11 (July 1997)
Brief Review – Growth Factors and Receptors
Cell Signaling by Receptor Tyrosine Kinases
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,
Successful targeting of ErbB2 receptors—is PTEN the key?
Update on glucocorticoid action and resistance
Presentation transcript:

Molecular regulation of mast cell activation Juan Rivera, PhD, Alasdair M. Gilfillan, PhD  Journal of Allergy and Clinical Immunology  Volume 117, Issue 6, Pages 1214-1225 (June 2006) DOI: 10.1016/j.jaci.2006.04.015 Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 1 Structure of FcɛRI and newly defined inhibitory motifs. FcɛRI on mast cells is comprised of an IgE-binding α chain, a 4-transmembrane-spanning β chain, and a homodimer of γ chains. Both the β and γ chains contain the ITAM. The β chain contains a noncanonical tyrosine at position 225, which is involved in the negative regulation of cytokine production in mast cells. A recent study shows that the γ chain ITAM can associate with both positive (ie, Syk) and negative (ie, SHP-1) effector molecules and in this manner mediate both positive and negative function. Journal of Allergy and Clinical Immunology 2006 117, 1214-1225DOI: (10.1016/j.jaci.2006.04.015) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 2 Simplified scheme of FcɛRI signaling events in mast cells. Engagement of FcɛRI results in inclusion in lipid rafts, phosphorylation (P) of receptor ITAMs by Lyn kinase, and activation of Syk kinase through ITAM binding. Fyn kinase is also activated and is important for phosphorylation of the adapter known as Gab2 and activation of PI3K activity. Lyn regulates the activation of Syk and phosphorylation of several adaptor proteins called LAT and NTAL. These proteins function as scaffolds and organize other signaling proteins that can affect Ras activation, PLCγ activation through the coordinated function of Gads/SLP-76/Vav1 and Tec family kinases, PI3K activity, and calcium responses. PLCγ activation can also be regulated independently of LAT through a PI3K/Btk-dependent pathway. MAP kinase and transcription factor activation is dependent on LAT (and possibly NTAL) leading to mast cell cytokine production and eicosanoid production through cPLA2 activation. PLCγ-generated DAG is key for early activation of PKC and mast cell cytokine production and degranulation. PI3K activity is also required for activation of PLD and SphK1. SphK generates S1P from sphingosine (Sph), which influences calcium mobilization and mast cell effector responses through cell-surface receptors for S1P (see text). The coordination of these molecular events is intrinsically regulated by both positive and negative functions of many of the components in the signaling cascade. Journal of Allergy and Clinical Immunology 2006 117, 1214-1225DOI: (10.1016/j.jaci.2006.04.015) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 3 Mechanism for regulation of Src family kinase activity in mast cells. The Csk-binding protein (Cbp) is a target of Lyn kinase activity in mast cells. Cbp is localized in lipid raft domains and is phosphorylated constitutively by Lyn in these domains and interacts with the Csk, a kinase that phosphorylates Src family kinases and inactivates them. FcɛRI stimulation increases the phosphorylation of Cbp, causing additional recruitment of Csk that then controls the activity of the Src family kinase Fyn by phosphorylating its negative regulator tyrosine at the C-terminus. The loss of Cbp phosphorylation and Csk recruitment in the absence of Lyn results in a constitutive increase of Fyn activity that is associated with enhanced mast cell degranulation. Journal of Allergy and Clinical Immunology 2006 117, 1214-1225DOI: (10.1016/j.jaci.2006.04.015) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 4 Cooperativity in the LAT-scaffolded signaling complex and structure of LAT and NTAL with potential or known interaction sites. A, LAT is a membrane-localized adaptor protein that is concentrated in lipid rafts. It binds both PLCγ and the Gad/Grb2 family of adaptor proteins, which coordinate the binding of other adaptor proteins or functional proteins, such as SLP-76 and Vav1. Interactions of these proteins with the Tec family kinases, such as ItK, are also key in stabilizing the complex. Phosphoinositides play an important role for membrane targeting through PH domains and can also function as substrates for PLCγ-dependent calcium signals (inositol trisphosphate) and PKC activation (DAG). Cooperativity is demonstrated by loss of normal complex function when a single protein is deleted from the complex. B, NTAL/LAB and LAT show high structural domain homology. Both adapters localize to lipid rafts and encode short extracytoplasmic regions and transmembrane domains. Both also possess a conserved palmytoylation motif (Cxxc) at the transmembrane cytosolic interface. Depicted are the conserved tyrosine residues (Y) of the human adapters. Also shown are binding sites for the Grb2 and Gads family of adapters (YxN). The location of the tyrosine residue and the consensus motif (YLVV) of PLCγ binding to LAT is shown. Journal of Allergy and Clinical Immunology 2006 117, 1214-1225DOI: (10.1016/j.jaci.2006.04.015) Copyright © 2006 American Academy of Allergy, Asthma and Immunology Terms and Conditions